Compare GGN & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GGN | INMD |
|---|---|---|
| Founded | 2005 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 877.0M | 842.0M |
| IPO Year | N/A | 2018 |
| Metric | GGN | INMD |
|---|---|---|
| Price | $5.29 | $14.42 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.33 |
| AVG Volume (30 Days) | 377.7K | ★ 594.6K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 10.26% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.74 |
| Revenue Next Year | N/A | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.15 | $12.72 |
| 52 Week High | $5.88 | $16.74 |
| Indicator | GGN | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 42.75 | 57.42 |
| Support Level | $5.18 | $14.24 |
| Resistance Level | $5.32 | $14.79 |
| Average True Range (ATR) | 0.07 | 0.28 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 19.12 | 65.59 |
GAMCO Global Gold Natural Resources & Income Trust is a non-diversified closed-end management investment company. Its primary investment objective is to provide a high current income and capital appreciation as its secondary objective. To achieve its objective, the fund may invest majority of its assets in equity securities of companies principally engaged in the gold and natural resources industries. It also intends to earn income through an option planning of writing (selling) covered call options on equity securities in its portfolio.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.